Close Menu

University of Maryland, Johns Hopkins University, and Georgetown University researchers dig into the "BRCAness" phenotype they produced in non-small cell lung cancers treated with a low dose DNA methyltransferase inhibitor (DNMTi). The team used expression array profiling and other analyses to examine the transition from BRCA-proficient NSCLC cell lines to those resembling BRCA-mutated tumors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.